Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Neurology Diabetes / Metabolic Women's Health Rheumatology Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting NCT07300254

Treponemal Shedding, Load, and Viability, in Women and Men-who-have-sex-with-women-only With Early Infectious Syphilis: Implications for Transmission

Treponemal Shedding, Load, and Viability, in Women and Men-who-have-sex-with-women-only With Early Infectious Syphilis: Implications for Transmission — Recruiting • Infectious Disease • NCT07300254.

📅 03 Apr 2026 ⏱ 3 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
NCT ID
NCT07300254
Sponsor
Monash University
Start
2025-12-02
ClinicaliQ Trial Snapshot
  • Treponemal Shedding, Load, and Viability, in Women and Men-who-have-sex-with-women-only With Early Infectious Syphilis: Implications for Transmission — Recruiting • Infectious Disease • NCT07300254.
  • How syphilis is transmitted between sexual partners is unclear. Asymptomatic detection i.e. detection of syphilis bacteria (Tp) from anatomical sites without lesions, in patients with syphilis infection, suggests that asymptomatic transmission from these sites may play a role. However, no existing studies….
  • Sponsor: Monash University.

Verify eligibility, endpoints and current status on the original source registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

How syphilis is transmitted between sexual partners is unclear. Asymptomatic detection i.e. detection of syphilis bacteria (Tp) from anatomical sites without lesions, in patients with syphilis infection, suggests that asymptomatic transmission from these sites may play a role. However, no existing studies have established whether the syphilis bacteria (Tp) detected was viable. This means it is not known if the bacteria at this anatomical site is alive and therefore able to transmit the infection. Further, studies have focused mostly on men who have sex with men, resulting in a lack…

Eligibility Snapshot
  • : - 1. Any cis-woman, cis-MSW, or nonbinary individuals with a penis who have sex with women only, (who meet all other study criteria) 2. Aged ≥18 years of age, 3. At least one sexual partner in the last 12 months 4. One of either: a. Untreated clinically suspected primary or secondary syphilis. i. Must have rash or lesion(s) clinically suggestive of early infectious syphilis infection. ii. May have positive PCR result, positive Dark-ground Microscopy result, positive syphilis serology or positive point-of-care syphilis test, but these are not necessary at the time of enrolment. b. Untreated early latent (no clinical signs indicative of primary or secondary syphilis) syphilis with positive syphilis serology or positive point-of-care test, and one or more of the following(11): i. A documented syphilis seroconversion within the prior 12 months. ii. A sustained (longer than 2 weeks) fourfold or greater increase in the titre in the prior 12 months in a person previously treated for syphilis. iii. Unequivocal symptoms of primary or secondary syphilis within the prior 12 months. iv. Contact in the prior 12 months with a sex partner who had untreated primary, secondary, or early latent syphilis. v. Documented reactive nontreponemal and treponemal tests,…

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Clinical Brief
‘Betrayed by my body’: The taboo health issue women are talking about on social media
Infectious Disease · BBC Health · 21 Oct 2026
Women are increasingly using social media to discuss chronic UTIs, helping to destigmatise a condition that many feel uncomfortable addressing with healthcare…
View brief →
Clinical Brief
Could gut parasites be influencing your behaviour?
Infectious Disease · BBC Health · 04 Jun 2026
Key Takeaways for Clinical Practice Parasitic infections may have behavioural effects in humans beyond traditional gastrointestinal symptoms, warranting consideration during psychiatric or…
View brief →
Clinical Brief
What is meningitis B and why is a vaccine only being offered to some teenagers?
Infectious Disease · BBC Health · 12 Jun 2026
Meningitis B Vaccine: Key Takeaways for Clinical Practice Limited NHS eligibility: Meningitis B vaccine is not routinely offered to all teenagers; only…
View brief →
Clinical Brief
UKHSA and PACE make new bacteria available to support research into tackling antimicrobial resistance
Infectious Disease · UKHSA · 22 Sep 2026
UKHSA and PACE have made WHO-priority threat bacteria available to researchers, expanding access to organisms critical for antimicrobial resistance (AMR) research and…
View brief →
Clinical Brief
Holidaymakers warned about ‘explosive diarrhoea’ cyclospora parasite infection
Infectious Disease · BBC Health · 30 Jul 2026
Cyclospora outbreaks are increasing in the UK (67 cases since April), primarily affecting recent travellers from Mexico—consider this diagnosis in patients presenting…
View brief →
Clinical Brief
Nearly 400 antibiotic-resistant infections each week in 2024
Infectious Disease · UKHSA · 29 Jun 2026
Antibiotic resistance remains a significant burden with ~400 resistant infections weekly in 2024, despite NHS prescribing falling below pre-pandemic levels Private sector…
View brief →